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Abstract
Aims/hypothesis We used the db/db mouse to determine the
nature of the secretory defect in intact islets.
Methods Glucose tolerance was compared in db/db and wild-
type (WT) mice. Isolated islets were used: to measure insulin
secretion and calcium in a two-photon assay of single-insulin-
granule fusion; and for immunofluorescence of soluble
N-ethylmaleimide-sensitive factor attachment proteins
(SNAREs).
Results The 13–18-week-old db/db mice showed a diabetic
phenotype. Isolated db/db islets showed a 77% reduction in
insulin secretion induced by 15 mmol/l glucose and reductions
in the amplitude and rise-time of the calcium response to
glucose. Ionomycin-induced insulin secretion in WT but not
db/db islets. Immunofluorescence showed an increase in the
levels of the SNAREs synaptosomal-associated protein 25
(SNAP25) and vesicle-associated membrane protein
2 (VAMP2) in db/db islets, but reduced syntaxin-1A.
Therefore, db/db islets have both a compromised calcium
response to glucose and a compromised secretory response to
calcium. Two-photon microscopy of isolated islets determined
the number and distribution of insulin granule exocytic events.
Compared with WT, db/db islets showed far fewer exocytic
events (an 83% decline at 15 mmol/l glucose). This decline
was due to a 73% loss of responding cells and, in the remaining
responsive cells, a 50% loss of exocytic responses per cell. An
assay measuring granule re-acidification showed evidence for
more recaptured granules in db/db islets compared with WT.
Conclusions/interpretation We showed that db/db islets had a
reduced calcium response to glucose and a reduction in
syntaxin-1A. Within the db/db islets, changes were manifest
as both a reduction in responding cells and a reduction in
fusing insulin granules per cell.
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Abbreviations
GK Goto-Kakizaki
GTT Glucose tolerance test
HPTS 8-Hydroxypyrene-1,3,6-trisulfonic acid
SNAP25 Synaptosomal-associated protein 25
SNARE Soluble N-ethylmaleimide-sensitive factor
attachment proteins
SRB Sulforhodamine B
VAMP2 Vesicle-associated membrane protein 2
WT Wild-type
Introduction
The db/db leptin receptor mutant mouse is a model for type 2
diabetes [1]. The animals gain weight and develop insulin intol-
erance and reduced insulin secretion [2]. The explanation for this
reduction in secretion, as in type 2 diabetes, is still not clear, but
may include: loss of islets; loss of beta cells [3]; loss of insulin
content [2, 4, 5]; or reduced exocytic capacity. Direct comparison
shows the proportionate loss of secretion parallels the loss of
insulin content: ∼4.5- to sixfold for both [4, 5]. However, even
though content is reduced, there is still more insulin present than
that required to maintain normoglycaemia [5]. This suggests
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defects in insulin secretion are important in the disease; an idea
supported bywork in humans [6, 7] and in othermodels of type 2
diabetes, such as the Goto-Kakizaki (GK) rat [8, 9].
The reduced insulin secretion could arise because of de-
fects anywhere along the complex stimulus-secretion cascade.
In db/db mice there is evidence for reduced GLUT2 expres-
sion [10, 11], and reduced ATP production [12]. The next step
in the cascade is the calcium response. In db/dbmice, both the
size [12] and the temporal profile of the calcium response are
altered [13]. Most recently, there is evidence, in other disease
models, for a mis-positioning of calcium channels relative to
the sites of insulin granule fusion [8, 14].
The final step of granule fusion is dependent on the soluble
N-ethylmaleimide-sensitive factor attachment proteins
(SNAREs). In db/db islets mRNA for synaptosomal-
associated protein 25 (SNAP25) and vesicle-associated mem-
brane protein 2 (VAMP2) increase and syntaxin-1A mRNA
decreases [15]. This contrasts with the GK rat, in which all
these SNAREs decrease [9, 16]. Functional studies in the GK
rat show a reduction in insulin granule fusion [17]. It has been
suggested that different modes of fusion might be prevalent in
models of ‘acute’ disease that use high-glucose or palmitate
exposure [18, 19]. Here, transient granule fusion, often termed
‘kiss-and-run’, could preferentially release low molecular
mass compounds and only partially release insulin [20]; if this
was the prevalent form of granule fusion in disease this could
explain the reduction in insulin secretion. However, the rele-
vance of full fusion or kiss-and-run fusion in islets is
questioned [21, 22] and possible roles are not known in animal
models of disease.
Within the intact islet it is known that the structure and
physical relationships between the cells are important for
secretion [23], and are factors that change in disease [3, 5].
To understand beta cell secretory function within an islet we
have developed a live-cell two-photon assay to measure
single-insulin-granule fusion events [24]. We have validated
this method on wild-type (WT) islets to prove that it measures
insulin granule fusion and that the time course and number of
fusion events fully account for the measured amount of insulin
secretion [24].While the method lacks the temporal resolution
of capacitance measurement [25], its key advantage is that it
records responses from all cells within the two-photon image
slice.
Using this method, we show here that the secretory deficit
in db/db islets is primarily due to a loss of responding cells and
a reduction in granule (full) fusion in the remaining responsive
cells.
Methods
Experimental solution Experiments were performed in an
extracellular solution (140 mmol/l NaCl, 5 mmol/l KCl,
1 mmol/l MgCl2, 2.5 mmol/l CaCl2, 5 mmol/l NaHCO3,
5 mmol/l HEPES and glucose [according to test conditions])
adjusted to pH 7.4 with NaOH.
Cell preparation Mice (BKS.Cg-Dock7m +/+ Leprdb/J, The
Jackson Laboratory, Bar Harbor, Maine, USA) were humane-
ly killed according to local University of Queensland animal
ethics procedures (approved by the University of Queensland
Anatomical Biosciences Ethics Committee). Isolated mouse
pancreatic tissue was prepared by a collagenase (type IV)
(Gibco, VIC, Australia) digestion method in Hanks buffer
(Sigma-Aldrich, Castle Hill, NSW, Australia), adjusted to
pH 7.4 with NaOH. Isolated islets were maintained (37°C,
95/5% air/CO2) in RPMI-1640 culture medium (Gibco, Life
Technologies, Mulgrave, VIC, Australia) supplemented with
10% FBS (Gibco) and 100 U/ml penicillin/0.1 mg/ml strep-
tomycin (Invitrogen, VIC, Australia).
Islet imaging Islets that had been cultured for 2–3 days were
pre-incubated in extracellular solution containing 3 mmol/l
glucose for 30min (37°C, 95/5% air/CO2) prior to two-photon
imaging (see ESM Methods).
Two-photon imaging We used a custom-made video-rate
two-photon microscope with a ×60 oil immersion ob-
jective (NA 1.42, Olympus, Macquarie Park, NSW,
Australia), providing an axial resolution (full width, half
maximum) of ∼1 μm. We imaged exocytic events using
sulforhodamine B (SRB, 800 μmol/l) as a membrane-
impermeant fluorescent extracellular marker excited by
femtosecond laser pulses at 950 nm, with fluorescence
emission detected at 550–650 nm. 8-Hydroxypyrene-
1,3,6-trisulfonic acid (HPTS) was excited at 950 nm
and emission detected at 420–520 nm.
Images (resolution 10 pixels/μm) were analysed with the
Metamorph program (Molecular Devices Corporation,
Sunnyvale, CA, USA). Exocytic event kinetics were mea-
sured from regions of interest (0.78 μm2, 78 pixels) centred
over individual granules. Traces were rejected if extensive
movement was observed.
Glucose tolerance test After an overnight fast (17:00 to
9:00 hours), fasting blood glucose concentrations were ob-
tained by the Accu-check Active (Roche, Castle Hill, NSW,
Australia) glucometer with a small drop of blood (∼5 μl) from
the tail tip. Then glucose 25% (wt/vol.) was injected intraper-
itoneally (1 g/kg) and blood samples were taken at 15, 30, 60,
90 and 120 min and glucose concentrations measured.
Immunofluorescence Isolated islets were fixed in 4% parafor-
maldehyde, permeabilised with Triton X-100 or saponin and
blocked with donkey serum prior to incubation with primary
antibodies (see ESM Methods).
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Insulin assay We used homogeneous time-resolved fluores-
cence (HTRF) with reagents supplied by Cisbio (HTRF
Insulin Kit [number 62INSPEB], Arundel, QLD, Australia)
to measure islet insulin secretion (see ESM Methods).
Calcium measurement For intracellular calcium measure-
ment, we used the ratiometric calcium indicator Fura 2-AM
(Molecular Probes, Life Technologies, see ESM Methods).
Statistical analyses Data are presented as mean ± SEM.
Statistical analyses were performed using Microsoft Excel
and GraphPad Prism. Data sets were subjected to a Student’s
t test; *p<0.05, **p<0.01 and ***p<0.001. Islets from at least
four animals were used in each experiment.
Results
The db/db mice have a diabetic phenotype The B6.BKS(D)-
Leprdb/db mice became significantly heavier than their WT
littermates (ESM Fig. 1a, n=38 mice, 13–18 weeks of age,
one-way ANOVA p<0.0001). At 13–18 weeks the db/db
mice showed significant differences in glucose tolerance
tests (GTTs), indicative of the development of diabetes
(ESM Fig. 1b, c; n=38 mice, one-way ANOVA
p<0.0001). These changes in the db/db animals are
due to both peripheral insulin resistance [2] and glucose
insensitivity of insulin secretion from the islets [2, 5].
Insulin secretion is reduced in db/db islets Islets were isolated
fromWTand db/dbmice, cultured for 2–3 days and tested for
glucose-dependent insulin secretion. We applied 15 mmol/l
glucose for 20 min and measured the secreted insulin. Islets
from db/dbmice had a significantly reduced response (Fig. 1a;
n=22 mice, Student’s t test, p<0.01). Together, the weight
gain, decreased GTT and reduction in insulin secretion are
















































































Fig. 1 Insulin secretion in db/db islets is decreased. (a) A static insulin
secretion assay, performed over 20 min, shows that the glucose-depen-
dent increase in insulin secretion in WT islets (white bars) is almost
completely lost in db/db islets (black bars), n=10–12 mice. (b) The
calcium response to glucose is smaller and slower in the db/db islets
(dotted line) compared with WT islets (solid line) (NB individual data
were aligned to the rising phase). For both WT and db/db islets, the
calcium response is relatively uniform across individual islets, n=20–30












































Fig. 2 Ionomycin fails to induce insulin secretion in db/db islets. (a) The
calcium response to ionomycin, measured as calibrated Fura 2-AM
fluorescence, in WT (solid line) and db/db islets (dotted line) have similar
kinetics, but db/db islets have a bigger magnitude. (b) A static insulin
assay, performed over 20 min, shows WT islets (white bars) respond to
ionomycin with a 1.6-fold increase in insulin secretion whereas the db/db
islets (black bars) show no response, n=11–12 mice. *p<0.05
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We next focused on studying the two distal steps of the
stimulus-secretion cascade: the rise in cytosolic calcium and
the exocytic fusion of insulin granules.
Calcium responses are attenuated in db/db islets Fura 2-AM-
loadedWT islets were stimulatedwith 15mmol/l glucose. The
calibrated fluorescent signals showed a rapid increase in cy-
tosolic calcium from 50 to ∼250 nmol/l (Fig. 1b) that appeared
relatively uniform across individual islets. In contrast, db/db
islets had significantly higher resting calcium levels (WT
37.6 nmol/l vs db/db 56.8 nmol/l, p<0.05) and a significantly
lower rate of increase in calcium (WT 3.48 nmol l−1 s−1 vs db/db
0.95 nmol l−1 s−1, p<0.001) and peak response to glucose
(Fig. 1b, WT 281.7 nmol/l vs db/db 193.0 nmol/l, p<0.01);
again, the calcium response was relatively uniform across the
islets.
The final stages of granule fusion are impaired in db/db
islets To test for a deficit in the last stage of the stimulus-
secretion cascade, we artificially raised cytosolic calcium using
5 μmol/l ionomycin. Ionomycin induced large cytosolic calci-
um responses in bothWTand db/db islets (Fig. 2a, n=14mice).
However, ionomycin-induced insulin secretion was observed
only in WT islets (Fig. 2b, n=23 mice). This shows that the
secretory response to a calcium signal is reduced in db/db islets
and demonstrates a specific defect in granule fusion.
Immunofluorescence was then used to determine the rela-
tive expression and distribution of SNAREs in the islets.
Based on insulin immunostaining, almost all the cells in the
core of the islets were beta cells (Fig. 3). SNAP25 and
syntaxin-1A localised to the beta cell membrane. And
VAMP2, the granule SNARE, was found within the cell.
Consistent with previous measurement of mRNA levels [15]
we show that levels of SNAP25 and VAMP2 proteins were
increased in the db/db islets but syntaxin-1A was reduced
(Fig. 3).
Taken together, our data indicate that the db/db islets have a
reduced calcium response to glucose and a compromised
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Fig. 3 SNARE protein
distribution and expression are
altered in db/db islets.
Immunofluorescence of fixed
islets shows insulin staining (red)
SNAP25, VAMP2 and syntaxin-
1A in beta cells. The histograms
show average fluorescence
intensity changes in db/db islets
normalised to WT and % of
fluorescence intensity in cytosol
regions compared with plasma
membrane regions in db/db and
WT islets, n>4 mice, 15–19
islets. Scale bar 10 μm.
***p<0.001. Syn1A, syntaxin-1A
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secretory response that is possibly due to a lower level of
syntaxin-1A.
Specific measurement of single-granule-fusion events in
islets To understand how these secretory defects are manifest
in an islet we exploited a two-photon assay to measure single-
granule-fusion events within the core of intact islets of
Langerhans [24], where almost all the cells in rodent islets
are beta cells. This assay tracks the entry of extracellular dye
as each insulin granule fuses; it has been extensively validated
in a previous paper [24].
Isolated islets were bathed in extracellular solution contain-
ing the fluorescent dye SRB and imaged with two-photon
microscopy [24, 27]. The concentration of extracellular glu-
cose was changed and the total numbers of fusion events
occurring within the two-photon sample volume
(∼40×50×1 μm) were recorded over 20 min. ESM Fig. 2
shows a single beta cell within an islet, where 15 mmol/l
glucose-induced five-granule-fusion events, with each event
showing a characteristic rapid rise in fluorescence after fusion
and then a slower decay back to baseline fluorescence.
Control WT islets showed a glucose-dose-dependent increase
in the number of fusion events, consistent with our previous
data (Fig. 4a, b; n=177 islets, 21 mice [24]). In contrast, islets
from db/db animals showed significantly lower numbers of
fusion events induced by glucose (Fig. 4, one-way ANOVA:
3 mmol/l, p=0.11; 6 mmol/l, p=0.061; 15 mmol/l, p=1.23×
10−9; 20 mmol/l p=8.24×10−8, e.g. an 83% loss at 15 mmol/l).
Further analysis demonstrates that, in response to 15 mmol/l
glucose, the number of responding cells in db/db islets was
reduced by 73% and the number of granule fusion events in the
remaining responsive cells was reduced by 50% (Fig. 4c,
ANOVA for number of responding cells: 3 mmol/l, p=0.15;
6 mmol/l, p=0.0096; 15 mmol/l, p=5.83×10−12; 20 mmol/l,
p=1.8×10−10). ANOVA for the number of fusion events per
responding cell: 3 mmol/l, p=0.38; 6 mmol/l, p=0.11;
15 mmol/l, p=0.0001; 20 mmol/l, p=9.12×10−8. While
we cannot identify cell type in this assay, the measured
perimeters of the responsive cells in control and db/db
islets were the same (ESM Fig. 3), suggesting both are
beta cells as the other possible cell types are a different
size [25].
The time course of the cumulative exocytic responses in
WT islets shows an increase, up to a plateau, in response to
15 mmol/l glucose (Fig. 4d). In contrast, db/db islets showed a
steady and small exocytic response.
These data show db/db beta cells have dramatically
reduced numbers of exocytic fusion events. However,
there may be additional variables of fusion that differ in
db/db cells. For example, the duration of granule fusion
and the behaviour of the granule after fusion could be
different and both could have an influence on the






















































































































Fig. 4 Within intact islets from db/db mice, beta cells have fewer
insulin granule fusion events. (a) Typical two-photon cross sec-
tions taken across intact islets include many cells. Each granule
fusion event over a 20 min time period is identified (as shown in
ESM Fig. 2) and its position marked as a yellow circle. Scale bar
10 μm. (b) Quantification of the numbers of granule fusion
events (in the two-photon volume, over 20 min), across a range
of glucose concentrations, shows a significant reduction in granule
fusion in db/db beta cells. The reduction in fusion events ob-
served occurs because of both (c) a decrease in the number of
responding cells and (d) a decrease in the number of fusion
events per responding cell. (e) Cumulative plots of insulin granule
fusion events over time, in response to 15 mmol/l glucose. n=4–9
mice and 175 islets; p values from ANOVA analysis: **p<0.01
and *** p<0.001. In b–d: white bars, WT; hatched bars, db/+; black bars,
db/db. In e: circles, WT; squares, db/+; and triangles, db/db
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Exocytic lifetimes and granule fusion characteristics are not
different in db/db beta cells We quantified granule fluores-
cence lifetimes, arbitrarily defining the start of the event as
where the fluorescence rose to the half maximal fluorescence
intensity and the end of the event when the signal dropped to
below the two standard deviations above the baseline fluores-
cence noise (Fig. 5a, start and end indicated by arrows).
Frequency–lifetime histograms show a model value of ∼4 s
(Fig. 5c and d;WT, n=743 events; db/db, n=314 events), with
no evidence for distinct populations of lifetimes, and no
differences between db/db and WT (Kolmogorov–Smirnov
test between WT and db/db, p=0.422).
Another variable is the fluorescence intensity post-fusion,
which is different for each granule (Fig. 6). In some fusion
events the fluorescence stays high; we have previously shown
that this reflects the retention of granule content (and dye)
within the granule lumen [29]. Figure 6a and b show two
examples of the fluorescence profile over time from two
different exocytic events. In one event there is a rapid loss of
fluorescence, while in the other the fluorescence signal is
maintained at a high intensity. To quantify this for each
granule fusion event, we measured the fluorescence intensity
15 s after the peak fluorescence, normalised this fluorescence
to the peak fluorescence and plotted out a frequency graph
(Fig. 6c). The modal value of this fluorescence signal was
around 0.3 (i.e. a plateau level of 30% of the peak fluores-
cence) and the distribution of values did not differ between
WT, db/+ and db/db islets (Kolmogorov–Smirnov test
between WT and db/db, p=0.514).
We conclude that, using our assays, the insulin granule
fusion events in db/db beta cells are indistinguishable from
those in WT cells.
Granule endocytosis After fusion, granule fluorescence







































































Fig. 6 The granule fluorescence plateaus are not changed in db/db cells.
Two examples of single-granule-fusion events: (a) a low fluorescence
plateau (fluorescence returns to background levels) (plateau=0.09); and
(b) a high fluorescence plateau (plateau=0.87). In each case the mean
fluorescence changes within a region of interest placed over the granule
fusion site is shown, as are images taken at 1 s intervals over the duration
of the fusion event. Scale bar 1 μm. (c) Graphs of frequency plotted
against fluorescence (SRB) plateau (normalised to the peak fluorescence)
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Fig. 5 Insulin granule fusion lifetimes are not changed in db/db cells.
Examples of (a) short and (b) longer granule lifetimes as identified by the
average fluorescence signal from regions of interest (ROIs) placed over
each individual fusion event. Arrows show the start and end of the event.
(c, d) Frequency graphs of the binned granule lifetimes;WT (c) and db/db
islets (d) have similar distributions; n=4–9 mice, total of 1,057 events
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lost, which we interpret as a collapse of the granule into the
cell membrane. However, another alternative granule behav-
iour is that the fusion pore can close while the granule is at the
cell membrane, sometime called ‘kiss-and-run’, which is well
documented in beta cells [20, 30]. After fusion pore closure
the granule lumen rapidly acidifies because of the action of the
granular vacuolar (v)ATPase [31].
To detect this pH shift we added a pH-sensitive dye (HPTS)
to the extracellular solution (in addition to SRB, which is pH
insensitive) and tracked the fluorescence changes after granule
fusion [32]. Acidification reduces the HPTS fluorescence
[33], and a different fluorescence signal between the two dyes
indicates granule recapture (Fig. 7). To quantify these changes
we define a ‘recaptured’ granule as one where, at 15 s after the
peak, the HPTS had dropped by more than 20% of the SRB
signal. This quantification demonstrates that the proportion of
granules that acidified was small but interestingly there were
significantly more recaptured granules (×1.75 increase) in the
db/db islets (Table 1; Student’s t test, p=0.022). We conclude
that transient fusion (kiss-and-run) is more common in the
db/db islets.
Discussion
The basis of the insulin secretory effect in type 2 diabetes is
still not fully understood. In principle, changes could occur in
the number of responding islets, number of beta cells or in the
secretory function of individual beta cells. Our data provide
clear evidence for a reduction in the number of responding
cells and a decrease in granule fusion.
Decrease in the number of responding cells We showed that
the number of glucose-responsive cells in the db/db islets was
reduced by 73%, indicating this is the major factor that explains
the loss of insulin secretion from islets. This pattern of loss of
cell responsiveness is the likely outcome of intrinsic defects in
both intracellular beta cell morphology [5] and function, in part
caused by endoplasmic reticulum stress [34], that result in
apoptosis and dedifferentiation [35]. There is also likely to be
a contribution from perturbation of intercellular communication
between the islet cells [36], much of which is unknown and
requires further study with approaches like ours to measure cell
activity within intact islets. The data we show are the first to
characterise the functional outcomes of these cellular changes
in diseased islets and demonstrate that complete loss of beta cell
function is the most significant factor contributing to the overall
loss of insulin secretion from islets.
Decrease in single-cell secretion We further show that in the
cells that remain responsive there is a 50% loss of exocytic
fusion. Our two-photon assay unequivocally identifies loss of
the number of granule fusion events as the manifestation of
this secretory defect. There are two other studies that have
looked at insulin granule fusion in models of disease. Using




























































Fig. 7 ‘Kiss-and-run’ granule
recapture is increased in the db/db
cells. Two extracellular dyes,
SRB (pH insensitive) (solid lines)
and HPTS (dashed lines) both
enter each fusing granule. (a) For
most granule fusion events the
average fluorescence intensity
changes are similar for both dyes.
(b) In contrast, some granule
fusion events show a selective
decrease in the HPTS signal
where it is quenched by
acidification. Scale bars 1 μm;
n=4 WT and n=4 db/db mice;
total of 580 events
Table 1 Proportions of acidifying (recaptured) granules inWTand db/db
islets
Islet Total exocytic events Number (%) of re-acidified events
WT 408 27 (6.6)
db/db 172 20 (11.6)
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fusion showed a reduction in fusion events [17]. The second
study used cultured single cells to show incubation in high
glucose selectively reduced full-fusion events compared with
transient fusion [19]. These studies are limited to single-cell
work, but both agree with our finding that loss of secretion in
the damaged beta cell is characterised by a loss of granule
fusion. Where our findings differ is that we see no evidence
that transient fusion is a significant contributor to the deficit in
insulin secretion and our method records the relative contri-
bution of the loss of responsive cells.
Secretory defect In the beta cells that poorly secrete, our data
suggest some important factors that might explain this reduc-
tion in secretory competence.
First, we show changes in calcium signalling that lead to an
increased resting calcium and a decreased response to glucose.
These observations are consistent with a single-cell study on
db/db beta cells [37], but in intact db/db islets there is evidence
for larger [13] and smaller [12] calcium responses. These
differences may reflect stages in disease progression in indi-
vidual animals, with the larger responses (also seen in the GK
rat model [8]) representing an early stage of compensatory
upregulation of responsiveness. To date, we have been unable
to reliably measure calcium and exocytosis simultaneously in
single cells within the islet and therefore cannot directly relate
the changed calcium responses to secretory output. However,
it seems reasonable that the reduced rate of increase in the
calcium signal and the reduced amplitude would lead to a
decreased exocytic response. Interestingly, the increased basal
calcium levels we observed could explain the increased basal
insulin secretion that we (Fig. 2) and others [13] see in the
db/db islets. Our whole-islet calcium measurement method
does not spatially or temporally resolve single-cell responses.
However, our observed slowed rate of rise of the db/db calci-
um response (Fig. 1b) is consistent with studies that indicate
displacement of calcium channels around the cells and away
from the sites of exocytosis [14]. What our work with
ionomycin clearly indicates is that, on top of a reduced
glucose-induced calcium response, there is also a specific loss
of exocytic competence in the db/db beta cells.
The second factor we identify are changes in the expression
of SNARE proteins which could contribute to this loss of
secretory competence. Interestingly, the increase in SNAP25
and VAMP2 and decrease in syntaxin-1A expression is the
same pattern as previously observed in db/dbmice using quan-
titative PCR [15], which demonstrates a specificity to the cell
damage. The changes in SNARE expression are consistent with
previous reports [9, 16, 38] and with evidence that manipula-
tion of SNARE expression changes insulin secretion [39].
However, if SNARE reduction was the only defect, it should
lead to granule accumulation, something observed in other cell
types with a SNARE defect [32]. In fact, in db/db islets the
granule density (per unit cell volume) is approximately half that
of WT [40], indicating that there must be additional factors that
are changed in disease. This reduction in granule numbers
alone does not explain the ∼80% reduction in granule fusion
we observe (Fig. 4) and leads us to conclude that the combina-
tion of loss of granules, changes in SNARE expression and
changes in the calcium signal all contribute to the secretory
defect. Such a multifaceted phenotype is consistent with gross
cellular changes due, for example, to dedifferentiation [35].
Changes in insulin granule fusion behaviour Our work shows
that granule lifetimes and the granule fluorescence plateaus
are not changed, indicating that the essential exocytic mech-
anisms are not altered in disease. The increase in kiss-and-run
events we observed could be due to the changed expression of
SNAREs. The increase in recaptured granules cannot explain
the loss of insulin secretion but, instead, could be part of the
mechanism of disease. For example, it has been observed that
diseased beta cells contain many granules (or at least granule-
like objects) in which the insulin crystal is absent [40]. It has
been speculated this is due to misprocessing of granule cargo
[40], an idea supported by work on mutations in the zinc
transporter [41]. But the increase in kiss-and-run events that
we observed would also be consistent with the appearance of
‘empty’ vesicles. If these ‘empty’ vesicles could not fuse
again then they could form a barrier to exocytosis of normal
vesicles and thus contribute to disease progression.
Conclusion Among the possible explanations of the diabetic
phenotype of db/db mice we here show that the major factors
are the loss of responding cells and the loss of the number of
fusing insulin granules.
Funding This work was supported by the Australian Research Council
(DP110100642 PT) and National Health and Medical Research Council
(APP1002520 and APP1059426 PT and HYG).
Duality of interest The authors confirm there is no duality of interest
associated with this manuscript.
Contribution statement All authors made contributions to the concep-
tion and design of the experiments. OHD and JTL performed the research
and developed the methods. PT and HYG designed the research. All
authors were involved in drafting and all approved the final version of the
manuscript. PT is responsible for the integrity of the work as a whole.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. LeeGH, Proenca R,Montez JM et al (1996) Abnormal splicing of the
leptin receptor in diabetic mice. Nature 379:632–635
Diabetologia (2014) 57:1400–1409 1407
2. Berglund O, Frankel BJ, Hellman B (1978) Development of insulin
secretory defect in genetically diabetic (db/db) mouse.
Acta Endocrinol 87:543–551
3. Baetens D, Stefan Y, Ravazzola M, Malaisselagae F, Coleman DL,
Orci L (1978) Alteration of islet cell-populations in spontaneously
diabetic mice. Diabetes 27:1–7
4. Ishida H, Takizawa M, Ozawa S et al (2004) Pioglitazone improves
insulin secretory capacity and prevents the loss of beta-cell mass in
obese diabetic db/db mice: possible protection of beta cells from
oxidative stress. Metabolism 53:488–494
5. Boquist L, Hellman B, Lernmark A, Taljedal IB (1974) Influence of
mutation diabetes on insulin release and islet morphology in mice of
different genetic backgrounds. J Cell Biol 62:77–89
6. Marchetti P, del Guerra S, Marselli L et al (2004) Pancreatic islets
from type 2 diabetic patients have functional defects and increased
apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab
89:5535–5541
7. Rosengren AH, Braun M, Mandi T et al (2012) Reduced insulin
exocytosis in human pancreatic beta-cells with gene variants linked
to type 2 diabetes. Diabetes 61:1726–1733
8. Rose T, Efendic S, Rupnik M (2007) Ca2+-secretion coupling
is impaired in diabetic Goto Kakizaki rats. J Gen Physiol
129:493–508
9. Nagamatsu S, Nakamichi Y, Yamamura C et al (1999) Decreased
expression of t-snare, syntaxin 1, and SNAP-25 in pancreatic beta-
cells is involved in impaired insulin secretion from diabetic GK rat
islets—restoration of decreased T-snare proteins improves impaired
insulin secretion. Diabetes 48:2367–2373
10. Thorens B, Wu YJ, Leahy JL, Weir GC (1992) The loss of GLUT2
expression by glucose-unresponsive beta-cells of db/db mice is re-
versible and is induced by the diabetic environment. J Clin Invest
90:77–85
11. Kjorholt C, Akerfeldt MC, Biden TJ, Laybutt DR (2005) Chronic
hyperglycemia, independent of plasma lipid levels, is sufficient for
the loss of beta-cell differentiation and secretory function in the db/db
mouse model of diabetes. Diabetes 54:2755–2763
12. Brenner MB, Gromada J, Efanov AM, Bokvist K, Mest HJ
(2003) Restoration of first-phase insulin secretion by the
imidazoline compound ly374284 in pancreatic islets of diabet-
ic db/db mice. In: Piletz JE, Regunathan S, Ernsberger P (eds)
Agmatine and imidazolines: their novel receptors and en-
zymes. Ann N Y Acad Sci 1009:332–340
13. RoeMW, Philipson LH, Frangakis CJ et al (1994) Defective glucose-
dependent endoplasmic-reticulum Ca2+ sequestration in diabetic
mouse islets of Langerhans. J Biol Chem 269:18279–18282
14. Hoppa MB, Collins S, Ramracheya R et al (2009) Chronic palmitate
exposure inhibits insulin secretion by dissociation of Ca2+ channels
from secretory granules. Cell Metab 10:455–465
15. Kaneko K, Ueki K, Takahashi N et al (2010) Class ia phos-
phatidylinositol 3-kinase in pancreatic beta cells controls insulin
secretion by multiple mechanisms. Cell Metab 12:619–632
16. Gaisano HY, Ostenson CG, Sheu L, Wheeler MB, Efendic S (2002)
Abnormal expression of pancreatic islet exocytotic soluble
n-ethylmaleimide-sensitive factor attachment protein receptors in
Goto-Kakizaki rats is partially restored by phlorizin treatment
and accentuated by high glucose treatment. Endocrinology
143:4218–4226
17. Ohara-Imaizumi M, Nishiwaki C, Kikuta T, Nagai S, Nakamichi Y,
Nagamatsu S (2004) Tirf imaging of docking and fusion of single
insulin granule motion in primary rat pancreatic beta-cells: different
behaviour of granule motion between normal and Goto-Kakizaki
diabetic rat beta-cells. Biochem J 381:13–18
18. Olofsson CS, Collins S, Bengtsson M et al (2007) Long-term expo-
sure to glucose and lipids inhibits glucose-induced insulin secretion
downstream of granule fusion with plasma membrane. Diabetes
56:1888–1897
19. Tsuboi T, Ravier MA, Parton LE, Rutter GA (2006) Sustained
exposure to high glucose concentrations modifies glucose signaling
and the mechanics of secretory vesicle fusion in primary rat pancre-
atic beta-cells. Diabetes 55:1057–1065
20. Eliasson L, Abdulkader F, Braun M, Galvanovskis J, Hoppa MB,
Rorsman P (2008) Novel aspects of the molecular mechanisms
controlling insulin secretion. J Physiol 586:3313–3324
21. Ma L, Bindokas VP, Kuznetsov A et al (2004) Direct imaging shows
that insulin granule exocytosis occurs by complete vesicle fusion.
Proc Natl Acad Sci U S A 101:9266–9271
22. Takahashi N, Kishimoto T, Nemoto T, Kadowaki T, Kasai H (2002)
Fusion pore dynamics and insulin granule exocytosis in the pancre-
atic islet. Science 297:1349–1352
23. Halban PA,Wollheim CB, Blondel B,Meda P, Niesor EN,Mintz DH
(1982) The possible importance of contact between pancreatic-islet
cells for the control of insulin release. Endocrinology 111:86–94
24. Low JT, Mitchell JM, Do OH et al (2013) Glucose principally
regulates insulin secretion in islets by controlling the numbers of
granule fusion events per cell. Diabetologia 56:2629–2637
25. Gopel S, ZhangQ, Eliasson L et al (2004) Capacitancemeasurements
of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within
intact islets of Langerhans. J Physiol 556:711–726
26. Kawasaki F, Matsuda M, Kanda Y, Inoue H, Kaku K (2005)
Structural and functional analysis of pancreatic islets pre-
served by pioglitazone in db/db mice. Am J Physiol 288:
E510–E518
27. Takahashi N, Hatakeyama H, Kasai H (2004) Sequential insulin
exocytosis and redistribution of SNAP25 analyzed with two-photon
imaging. Diabetologia 47:205
28. Rutter GA, Tsuboi T (2004) Kiss and run exocytosis of dense core
secretory vesicles. Neuroreport 15:79–81
29. Thorn P, Parker I (2005) Two phases of zymogen granule lifetime in
mouse pancreas: ghost granules linger after exocytosis of contents.
J Physiol 563:433–442
30. Tsuboi T, McMahon HT, Rutter GA (2004) Mechanisms of
dense core vesicle recapture following ‘kiss and run’
(‘cavicapture’) exocytosis in insulin-secreting cells. J Biol Chem
279:47115–47124
31. Ohara-Imaizumi M, Nakamichi Y, Tanaka T, Katsuta H, Ishida H,
Nagamatsu S (2002) Monitoring of exocytosis and endocytosis of
insulin secretory granules in the pancreatic beta-cell line min6 using
ph-sensitive green fluorescent protein (pHluorin) and confocal laser
microscopy. Biochem J 363:73–80
32. Behrendorff N, Dolai S, Hong WJ, Gaisano HY, Thorn P (2011)
Vesicle-associated membrane protein 8 (vamp8) is a snare (soluble n-
ethylmaleimide-sensitive factor attachment protein receptor) selec-
tively required for sequential granule-to-granule fusion. J Biol Chem
286:29627–29634
33. Behrendorff N, Floetenmeyer M, Schwiening C, Thorn P (2010)
Protons released during pancreatic acinar cell secretion acidify
the lumen and contribute to pancreatitis in mice. Gastroenterology
139:1711–1719
34. Laybutt DR, Preston AM, Akerfeldt MC et al (2007) Endoplasmic
reticulum stress contributes to beta cell apoptosis in type 2 diabetes.
Diabetologia 50:752–763
35. Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta
cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell
150:1223–1234
36. Speier S, Gjinovci A, Charollais A, Meda P, Rupnik M (2007) Cx36-
mediated coupling reduces beta-cell heterogeneity, confines the stimu-
lating glucose concentration range, and affects insulin release kinetics.
Diabetes 56:1078–1086
37. GustavssonN, Larsson-Nyren G, Lindstrom P (2005) Pancreatic beta
cells from db/db mice show cell-specific Ca2+ (i) and NADH
responses to glucose but not to alpha-ketoisocaproic acid. Pancreas
31:242–250
1408 Diabetologia (2014) 57:1400–1409
38. Ostenson CG, Gaisano H, Sheu L, Tibell A, Bartfai T (2006)
Impaired gene and protein expression of exocytotic soluble
n-ethylmaleimide attachment protein receptor complex proteins in
pancreatic islets of type 2 diabetic patients. Diabetes 55:435–440
39. Spurlin BA, Thurmond DC (2006) Syntaxin 4 facilitates biphasic
glucose-stimulated insulin secretion from pancreatic beta-cells.
Mol Endocrinol 20:183–193
40. Xue YH, Zhao W, DuWet al (2012) Ultra-structural study of insulin
granules in pancreatic beta-cells of db/db mouse by scanning trans-
mission electron microscopy tomography. Protein Cell 3:521–525
41. Nicolson TJ, Bellomo EA, Wijesekara N et al (2009) Insulin storage
and glucose homeostasis in mice null for the granule zinc transporter
znt8 and studies of the type 2 diabetes-associated variants. Diabetes
58:2070–2083
Diabetologia (2014) 57:1400–1409 1409
